Galectin-9—An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy.

Saved in:
Bibliographic Details
Title: Galectin-9—An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy.
Authors: Karkempetzaki, Anastasia Iris1,2,3 (AUTHOR), Schatton, Tobias1,2,4 (AUTHOR) tschatton@bwh.harvard.edu, Barthel, Steven R.1,2,3 (AUTHOR) sbarthel@bwh.harvard.edu
Source: International Journal of Molecular Sciences. Aug2025, Vol. 26 Issue 16, p7998. 38p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms26167998